An Exosomal Urinary miRNA Signature for Early Diagnosis of Renal Fibrosis in Lupus Nephritis
暂无分享,去创建一个
[1] Systemic Lupus Erythematosus Disease Activity Index , 2020, Definitions.
[2] P. Udagama,et al. Selected serum cytokines and nitric oxide as potential multi-marker biosignature panels for Parkinson disease of varying durations: a case-control study , 2019, BMC Neurology.
[3] A. Gholaminejad,et al. Identification of candidate microRNA biomarkers in renal fibrosis: a meta-analysis of profiling studies , 2018, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.
[4] Wang Yi-li,et al. Liquid biopsy biomarkers of renal interstitial fibrosis based on urinary exosome. , 2018, Experimental and molecular pathology.
[5] Yang Zhou,et al. Non-Proximal Renal Tubule-Derived Urinary Exosomal miR-200b as a Biomarker of Renal Fibrosis , 2018, Nephron.
[6] J. Lv,et al. A PEG-based method for the isolation of urinary exosomes and its application in renal fibrosis diagnostics using cargo miR-29c and miR-21 analysis , 2018, International Urology and Nephrology.
[7] M. Rots,et al. TCTN2: a novel tumor marker with oncogenic properties , 2017, Oncotarget.
[8] R. S. Conlan,et al. Exosomes as Reconfigurable Therapeutic Systems. , 2017, Trends in molecular medicine.
[9] D. Yap,et al. Recent advances in the understanding of renal inflammation and fibrosis in lupus nephritis , 2017, F1000Research.
[10] S. Beddhu,et al. Extracellular microRNA signature in chronic kidney disease. , 2017, American journal of physiology. Renal physiology.
[11] B. Rovin,et al. Update on Lupus Nephritis. , 2017, Clinical journal of the American Society of Nephrology : CJASN.
[12] Saveria Mazzara,et al. CombiROC: an interactive web tool for selecting accurate marker combinations of omics data , 2017, Scientific Reports.
[13] Kathleen E. Sullivan,et al. New insights into the immunopathogenesis of systemic lupus erythematosus , 2016, Nature Reviews Rheumatology.
[14] C. Ponticelli,et al. Lupus nephritis: When and how often to biopsy and what does it mean? , 2016, Journal of autoimmunity.
[15] A. Józkowicz,et al. TGF-β1/Smads and miR-21 in Renal Fibrosis and Inflammation , 2016, Mediators of inflammation.
[16] N. Zhang,et al. miR‐410 suppresses the expression of interleukin‐6 as well as renal fibrosis in the pathogenesis of lupus nephritis , 2016, Clinical and experimental pharmacology & physiology.
[17] M. Rudnicki,et al. Renal microRNA‐ and RNA‐profiles in progressive chronic kidney disease , 2016, European journal of clinical investigation.
[18] Paolo Aretini,et al. The combination of four molecular markers improves thyroid cancer cytologic diagnosis and patient management , 2015, BMC Cancer.
[19] J. Ordi‐Ros,et al. miR-29c in urinary exosomes as predictor of early renal fibrosis in lupus nephritis. , 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[20] Artemis G. Hatzigeorgiou,et al. DIANA-miRPath v3.0: deciphering microRNA function with experimental support , 2015, Nucleic Acids Res..
[21] Jun Li,et al. TGF-β/Smad signaling in renal fibrosis , 2015, Front. Physiol..
[22] B. Carter,et al. Extracellular vesicles as a platform for ‘liquid biopsy’ in glioblastoma patients , 2014, Expert review of molecular diagnostics.
[23] Lesley Cheng,et al. Characterization and deep sequencing analysis of exosomal and non-exosomal miRNA in human urine. , 2014, Kidney International.
[24] J. Coresh,et al. Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. , 2014, JAMA.
[25] P. Barbry,et al. FibromiRs: translating molecular discoveries into new anti-fibrotic drugs. , 2014, Trends in pharmacological sciences.
[26] L. Lv,et al. MicroRNA-29c in urinary exosome/microvesicle as a biomarker of renal fibrosis. , 2013, American journal of physiology. Renal physiology.
[27] Mingxia Xiong,et al. Sp1 mediates microRNA-29c-regulated type I collagen production in renal tubular epithelial cells. , 2013, Experimental cell research.
[28] G. Illei,et al. miR-150 promotes renal fibrosis in lupus nephritis by downregulating SOCS1. , 2013, Journal of the American Society of Nephrology : JASN.
[29] S. Friedman,et al. Therapy for Fibrotic Diseases: Nearing the Starting Line , 2013, Science Translational Medicine.
[30] F. Marabita,et al. Identification of New Autoantigens by Protein Array Indicates a Role for IL4 Neutralization in Autoimmune Hepatitis* , 2012, Molecular & Cellular Proteomics.
[31] T. Wynn,et al. Mechanisms of fibrosis: therapeutic translation for fibrotic disease , 2012, Nature Medicine.
[32] F. Hamdy,et al. An evaluation of urinary microRNA reveals a high sensitivity for bladder cancer , 2012, British Journal of Cancer.
[33] U. Jeschke,et al. Two-marker combinations for preoperative discrimination of benign and malignant ovarian masses. , 2012, Anticancer research.
[34] R. Colvin,et al. Renal interstitial fibrosis: mechanisms and evaluation , 2012, Current opinion in nephrology and hypertension.
[35] F. Hamdy,et al. Changes in circulating microRNA levels associated with prostate cancer , 2012, British Journal of Cancer.
[36] E. Abraham,et al. Identification of a microRNA signature in renal fibrosis: role of miR-21. , 2011, American journal of physiology. Renal physiology.
[37] Glen McGillivary,et al. Ribonuclease 7 is a potent antimicrobial peptide within the human urinary tract. , 2011, Kidney international.
[38] Chi-Ying F. Huang,et al. miRTarBase: a database curates experimentally validated microRNA–target interactions , 2010, Nucleic Acids Res..
[39] P. Boor,et al. Renal fibrosis: novel insights into mechanisms and therapeutic targets , 2010, Nature Reviews Nephrology.
[40] Gang Wang,et al. Expression of MicroRNAs in the Urinary Sediment of Patients with IgA Nephropathy , 2010, Disease markers.
[41] T. Kassimatis,et al. Transcription Factor Sp1 Expression Is Upregulated in Human Glomerulonephritis: Correlation with pSmad2/3 and p300 Expression and Renal Injury , 2010, Renal failure.
[42] N. Hirankarn,et al. Decreased renal expression of vascular endothelial growth factor in lupus nephritis is associated with worse prognosis. , 2009, Kidney international.
[43] C. Schmid,et al. A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.
[44] Pil Je Park,et al. The multiplex bead array approach to identifying serum biomarkers associated with breast cancer , 2009, Breast Cancer Research.
[45] F. Slack,et al. Small non-coding RNAs in animal development , 2008, Nature Reviews Molecular Cell Biology.
[46] J. Lötvall,et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells , 2007, Nature Cell Biology.
[47] Y. Tomino,et al. Pravastatin Inhibits Carboxymethyllysine-Induced Monocyte Chemoattractant Protein 1 Expression in Podocytes via Prevention of Signalling Events , 2007, Nephron Experimental Nephrology.
[48] Lee Hebert,et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. , 2004, Kidney international.
[49] D. Gladman,et al. Systemic lupus erythematosus disease activity index 2000. , 2002, The Journal of rheumatology.
[50] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[51] D. Mason,et al. Double immunofluorescence labelling of routinely processed paraffin sections , 2000, The Journal of pathology.
[52] M. Hochberg,et al. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. , 1997, Arthritis and rheumatism.
[53] J. Klippel,et al. Prognostic factors in lupus nephritis. Contribution of renal histologic data. , 1983, The American journal of medicine.
[54] Jianguo Xia,et al. miRNet-Functional Analysis and Visual Exploration of miRNA-Target Interactions in a Network Context. , 2018, Methods in molecular biology.
[55] R. Colvin,et al. Renal Interstitial Fibrosis: Mechanisms and Evaluation In: Current Opinion in Nephrology and Hypertension , 2022 .